
Sign up to save your podcasts
Or


Joe and Eric speak with Charley Hooper, author of the book Should the FDA Reject Itself? Part one of their discussion explores the likely impact of the Inflation Reduction Act and its drug pricing provisions, which include: overall drug production, the total impact on inflation, as well as the irony of prices actually going up as a result. *Episode aired Oct 26, 2022*
By Stay On Course Studios5
1212 ratings
Joe and Eric speak with Charley Hooper, author of the book Should the FDA Reject Itself? Part one of their discussion explores the likely impact of the Inflation Reduction Act and its drug pricing provisions, which include: overall drug production, the total impact on inflation, as well as the irony of prices actually going up as a result. *Episode aired Oct 26, 2022*

153,955 Listeners

4,274 Listeners

4,883 Listeners

702 Listeners

6,610 Listeners

334 Listeners

3,345 Listeners

35 Listeners

40,558 Listeners

6,249 Listeners

717 Listeners

453 Listeners

8,776 Listeners

17,008 Listeners

1,444 Listeners